EWTX [NASD]
Edgewise Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.21 Insider Own9.60% Shs Outstand63.21M Perf Week-9.78%
Market Cap546.57M Forward P/E- EPS next Y-1.58 Insider Trans26.93% Shs Float62.64M Perf Month-5.74%
Income-60.90M PEG- EPS next Q-0.34 Inst Own- Short Float / Ratio5.68% / 11.96 Perf Quarter-17.73%
Sales- P/S- EPS this Y-216.90% Inst Trans26.45% Short Interest3.56M Perf Half Y45.01%
Book/sh6.97 P/B1.27 EPS next Y-31.40% ROA-20.40% Target Price23.80 Perf Year-45.81%
Cash/sh5.91 P/C1.50 EPS next 5Y- ROE-21.30% 52W Range5.41 - 22.41 Perf YTD-42.02%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-60.46% Beta-
Dividend %- Quick Ratio27.80 Sales past 5Y- Gross Margin- 52W Low63.92% ATR0.66
Employees50 Current Ratio27.80 Sales Q/Q- Oper. Margin- RSI (14)40.03 Volatility7.15% 7.07%
OptionableYes Debt/Eq0.00 EPS Q/Q-28.40% Profit Margin- Rel Volume0.69 Prev Close8.58
ShortableYes LT Debt/Eq0.00 EarningsNov 03 BMO Payout- Avg Volume297.57K Price8.86
Recom2.00 SMA20-9.39% SMA50-10.01% SMA200-5.76% Volume205,267 Change3.26%
Aug-25-22Downgrade Goldman Neutral → Sell $5
Apr-13-22Initiated RBC Capital Mkts Outperform $31
Jan-28-22Initiated Goldman Neutral $11
Nov-14-22 09:55AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
Oct-27-22 04:05PM
Oct-25-22 12:00PM
09:55AM Loading…
09:55AM
Oct-13-22 04:30PM
Oct-06-22 08:00AM
Sep-23-22 06:35PM
Sep-16-22 04:05PM
Sep-13-22 09:17PM
05:04PM
08:49AM
Sep-11-22 05:00PM
Sep-07-22 08:00AM
08:30AM Loading…
Aug-31-22 08:30AM
Aug-04-22 08:00AM
Aug-03-22 08:00AM
Jul-18-22 11:44AM
Jul-12-22 08:00AM
Jun-22-22 01:53PM
Jun-21-22 08:47AM
Jun-20-22 08:00AM
Jun-16-22 08:00AM
May-31-22 08:00AM
May-11-22 08:00AM
May-03-22 08:00AM
Apr-28-22 11:45AM
Apr-14-22 08:00AM
Mar-24-22 11:11AM
08:00AM Loading…
Mar-08-22 08:00AM
Feb-24-22 08:00AM
Feb-03-22 04:35PM
Feb-02-22 09:00AM
Jan-10-22 07:40PM
Jan-05-22 09:15AM
08:00AM
Dec-15-21 09:00AM
Nov-17-21 09:00AM
Nov-10-21 08:00AM
Nov-04-21 11:23AM
Oct-28-21 07:29AM
06:00AM
Oct-11-21 03:56PM
Oct-06-21 11:45AM
Oct-01-21 11:09AM
Sep-25-21 09:57AM
Sep-14-21 09:00AM
Aug-16-21 09:00AM
Aug-09-21 09:00AM
Aug-04-21 09:00AM
Jul-28-21 10:45AM
Jun-27-21 05:12AM
Jun-22-21 09:00AM
Jun-01-21 09:00AM
May-13-21 04:01PM
May-04-21 09:00AM
Apr-27-21 09:00AM
Apr-16-21 07:31PM
Mar-30-21 04:01PM
08:06AM
Mar-25-21 10:23PM
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOORE JOHN RGeneral CounselOct 03Option Exercise1.934,7309,1297,730Oct 05 04:42 PM
MOORE JOHN RGeneral CounselOct 03Sale9.764,73046,1553,000Oct 05 04:42 PM
Thompson Peter A.DirectorSep 16Buy10.32484,4964,999,99913,981,952Sep 16 04:34 PM
ORBIMED ADVISORS LLCDirectorSep 16Buy10.32484,4964,999,99913,981,952Sep 16 04:31 PM
Novo Holdings A/S10% OwnerSep 14Buy10.32484,4964,999,9996,071,703Sep 16 02:35 PM
MOORE JOHN RGeneral CounselSep 06Option Exercise1.934,7309,1297,730Sep 08 04:16 PM
MOORE JOHN RGeneral CounselSep 06Sale10.914,73051,5983,000Sep 08 04:16 PM
MOORE JOHN RGeneral CounselAug 03Option Exercise1.349,23212,32512,232Aug 05 04:12 PM
MOORE JOHN RGeneral CounselAug 03Sale9.319,23285,9213,000Aug 05 04:12 PM
MOORE JOHN RGeneral CounselJul 06Option Exercise1.931,0462,0194,046Jul 07 04:23 PM
MOORE JOHN RGeneral CounselJul 06Sale8.541,0468,9283,000Jul 07 04:23 PM
MOORE JOHN RGeneral CounselJul 05Option Exercise1.268,18610,30711,186Jul 07 04:23 PM
MOORE JOHN RGeneral CounselJul 05Sale8.358,18668,3293,000Jul 07 04:23 PM
MOORE JOHN RGeneral CounselJun 21Option Exercise1.4031,07843,50134,078Jun 21 06:50 PM
MOORE JOHN RGeneral CounselJun 21Sale7.2931,078226,6953,000Jun 21 06:50 PM
MOORE JOHN RGeneral CounselJun 17Option Exercise1.9322,12742,70525,127Jun 21 06:50 PM
MOORE JOHN RGeneral CounselJun 17Sale6.6222,127146,4343,000Jun 21 06:50 PM
MOORE JOHN RGeneral CounselJun 16Option Exercise1.9314,72228,41317,722Jun 21 06:50 PM
MOORE JOHN RGeneral CounselJun 16Sale6.1714,72290,8053,000Jun 21 06:50 PM
MOORE JOHN RGeneral CounselJun 15Option Exercise0.7518,66013,96221,660Jun 15 06:39 PM
MOORE JOHN RGeneral CounselJun 15Sale6.1118,660114,0203,000Jun 15 06:39 PM
MOORE JOHN RGeneral CounselJun 14Option Exercise0.713,6282,5766,628Jun 15 06:39 PM
MOORE JOHN RGeneral CounselJun 14Sale6.023,62821,8553,000Jun 15 06:39 PM
MOORE JOHN RGeneral CounselJun 13Option Exercise0.714,0932,9067,093Jun 15 06:39 PM
MOORE JOHN RGeneral CounselJun 13Sale6.014,09324,5823,000Jun 15 06:39 PM
MOORE JOHN RGeneral CounselJun 10Option Exercise0.717,1255,05910,125Jun 10 06:34 PM
MOORE JOHN RGeneral CounselJun 10Sale6.057,12543,1203,000Jun 10 06:34 PM
MOORE JOHN RGeneral CounselJun 09Option Exercise0.717,6155,40710,615Jun 10 06:34 PM
MOORE JOHN RGeneral CounselJun 09Sale6.497,61549,3973,000Jun 10 06:34 PM
MOORE JOHN RGeneral CounselJun 08Option Exercise0.7112,5668,92215,566Jun 10 06:34 PM
MOORE JOHN RGeneral CounselJun 08Sale6.6312,56683,3623,000Jun 10 06:34 PM
MOORE JOHN RGeneral CounselJun 07Option Exercise0.7818,12314,05420,150Jun 07 07:03 PM
MOORE JOHN RGeneral CounselJun 07Sale6.6118,123119,7023,000Jun 07 07:03 PM
MOORE JOHN RGeneral CounselJun 06Option Exercise1.9313,93426,89316,934Jun 07 07:03 PM
MOORE JOHN RGeneral CounselJun 06Sale6.0313,93484,0853,000Jun 07 07:03 PM
MOORE JOHN RGeneral CounselJun 03Option Exercise1.9315,23029,39418,230Jun 07 07:03 PM
MOORE JOHN RGeneral CounselJun 03Sale6.0515,23092,1983,000Jun 07 07:03 PM
Carruthers R MichaelChief Financial OfficerMay 23Option Exercise0.719,0006,39012,000May 25 06:11 PM
ORBIMED ADVISORS LLCDirectorMay 18Buy7.21138,000994,98013,497,456May 20 04:38 PM
Thompson Peter A.DirectorMay 18Buy7.21138,000994,98013,497,456May 20 04:32 PM
MOORE JOHN RGeneral CounselMay 16Sale7.4210,80080,1463,000May 18 05:15 PM
MOORE JOHN RGeneral CounselJan 21Option Exercise0.715,4003,83412,362Jan 25 06:50 PM
MOORE JOHN RGeneral CounselDec 28Option Exercise0.715,4003,8346,962Dec 30 05:51 PM